NO20020777D0 - Pharmaceutical preparations containing derivatives and process for their preparation - Google Patents

Pharmaceutical preparations containing derivatives and process for their preparation

Info

Publication number
NO20020777D0
NO20020777D0 NO20020777A NO20020777A NO20020777D0 NO 20020777 D0 NO20020777 D0 NO 20020777D0 NO 20020777 A NO20020777 A NO 20020777A NO 20020777 A NO20020777 A NO 20020777A NO 20020777 D0 NO20020777 D0 NO 20020777D0
Authority
NO
Norway
Prior art keywords
preparation
pharmaceutical preparations
preparations containing
containing derivatives
derivatives
Prior art date
Application number
NO20020777A
Other languages
Norwegian (no)
Other versions
NO20020777L (en
Inventor
Robin Edwin Buckingham
Michael Urquhart
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9919465.6A external-priority patent/GB9919465D0/en
Priority claimed from GBGB9919842.6A external-priority patent/GB9919842D0/en
Priority claimed from GBGB9920149.3A external-priority patent/GB9920149D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of NO20020777D0 publication Critical patent/NO20020777D0/en
Publication of NO20020777L publication Critical patent/NO20020777L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
NO20020777A 1999-08-17 2002-02-15 Pharmaceutical preparations containing derivatives and process for their preparation NO20020777L (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9919465.6A GB9919465D0 (en) 1999-08-17 1999-08-17 Novel compounds
GBGB9919842.6A GB9919842D0 (en) 1999-08-20 1999-08-20 Novel compounds
GBGB9920149.3A GB9920149D0 (en) 1999-08-25 1999-08-25 Novel compounds
PCT/EP2000/007926 WO2001012628A1 (en) 1999-08-17 2000-08-14 Pharmaceutical compositions containing thiazolidinedione derivatives and process for their preparation

Publications (2)

Publication Number Publication Date
NO20020777D0 true NO20020777D0 (en) 2002-02-15
NO20020777L NO20020777L (en) 2002-02-15

Family

ID=27269792

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20020777A NO20020777L (en) 1999-08-17 2002-02-15 Pharmaceutical preparations containing derivatives and process for their preparation

Country Status (15)

Country Link
EP (1) EP1202991A1 (en)
JP (1) JP2003507379A (en)
KR (1) KR20020022812A (en)
CN (1) CN1379776A (en)
AU (1) AU7408900A (en)
BR (1) BR0013375A (en)
CA (1) CA2381976A1 (en)
CZ (1) CZ2002531A3 (en)
HU (1) HUP0202438A2 (en)
IL (1) IL148164A0 (en)
MX (1) MXPA02001716A (en)
NO (1) NO20020777L (en)
PL (1) PL353886A1 (en)
TR (1) TR200200438T2 (en)
WO (1) WO2001012628A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1284291A4 (en) * 2000-05-25 2005-06-08 Yamanouchi Pharma Co Ltd Human pgc-1 promoter
WO2003029251A1 (en) * 2001-09-28 2003-04-10 Biocon Limited Novel process for the synthesis of thiazolidinedione derivatives
GB0129871D0 (en) * 2001-12-13 2002-02-06 Smithkline Beecham Plc Novel pharmaceutical
GB0130509D0 (en) * 2001-12-20 2002-02-06 Smithkline Beecham Plc Novel pharmaceutical
KR100450700B1 (en) * 2002-03-22 2004-10-01 주식회사종근당 Thiazolidinedione derivatives and pharmaceutical composition comprising the same
KR20050068860A (en) 2003-12-30 2005-07-05 엘지.필립스 엘시디 주식회사 Upper substrate for use in dual-plate organic electroluminescent device and method for fabricating the same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10199003I1 (en) * 1987-09-04 2003-06-12 Beecham Group Plc Substituted thiazolidine ion derivatives
GB8919417D0 (en) * 1989-08-25 1989-10-11 Beecham Group Plc Novel compounds
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
CN1083715C (en) * 1994-02-10 2002-05-01 史密丝克莱恩比彻姆有限公司 Use of insulin sensitisers for treating renal diseases

Also Published As

Publication number Publication date
WO2001012628A1 (en) 2001-02-22
CN1379776A (en) 2002-11-13
CZ2002531A3 (en) 2002-07-17
JP2003507379A (en) 2003-02-25
CA2381976A1 (en) 2001-02-22
IL148164A0 (en) 2002-09-12
NO20020777L (en) 2002-02-15
KR20020022812A (en) 2002-03-27
AU7408900A (en) 2001-03-13
EP1202991A1 (en) 2002-05-08
MXPA02001716A (en) 2002-08-06
BR0013375A (en) 2002-07-23
PL353886A1 (en) 2003-12-01
TR200200438T2 (en) 2002-05-21
HUP0202438A2 (en) 2002-12-28

Similar Documents

Publication Publication Date Title
NO20021401D0 (en) Conazoline compounds and pharmaceutical preparations containing such compounds
NO20001409L (en) Carboxamidothiazole derivatives, processes for their preparation and pharmaceutical compositions
EE200100431A (en) 16-haloepothilone derivatives, process for their preparation and pharmaceutical use
HUP0201711A3 (en) N-indanyl-benzamide derivatives, method for their production, their use and pharmaceutical preparations containing them
NO20016277D0 (en) Systems and methods for aerolizing pharmaceutical formulations
NO20013736L (en) Pyrazole Carboxylic Acid Derivatives, their Preparation and Pharmaceutical Preparations Containing the Same
NO20002835L (en) 2-aryl-oxodihydropurine derivatives, process for the preparation of these medicinal preparations containing them, and intermediates therefor
NO985368L (en) Substituted imidazolidine derivatives, their preparation, their use and pharmaceutical preparations containing the compounds
ATE332132T1 (en) IMPROVED MEDICINAL PREPARATIONS CONTAINING RITONAVIR
NO984309L (en) New imidazolidine derivatives, their preparation, their use and pharmaceutical preparations containing them
NO20015659D0 (en) Purine derivatives, method of preparation and pharmaceutical compositions containing them
EE200100422A (en) Epothilone derivatives, process for their preparation and pharmaceutical use
NO20003662L (en) Synthetic polysaccharides, processes for their preparation and pharmaceutical preparations containing such
NO994659D0 (en) New pyridine derivatives and pharmaceutical preparations containing them
EE200300135A (en) Tryptamine derivatives and related compounds and pharmaceutical preparations containing them
NO930796D0 (en) GLYCOPEPTY DERIVATIVES, PROCEDURE FOR THEIR PREPARATION AND PHARMACEUTICAL AGENTS CONTAINING THESE
NO20013878L (en) (1-Phenacy-3-phenyl-3-piperidylethyl) piperidine derivatives, process for their preparation and pharmaceutical preparations containing the same
NO20020777D0 (en) Pharmaceutical preparations containing derivatives and process for their preparation
NO20014803D0 (en) Pyrido-thienodiazepines, process for their preparation and pharmaceutical compositions containing them
NO20016404D0 (en) Naphthyridine derivatives, processes for their preparation, their use and pharmaceutical compositions comprising them
NO20014632L (en) New morpholine derivatives, processes for their preparation and pharmaceutical preparations containing said derivatives
NO20013141D0 (en) Arylalkanoyl derivatives, processes for their preparation, their use and pharmaceutical products containing them
PT1206253E (en) SOLUBLE PHARMACEUTICAL PREPARATIONS CONTAINING NITROGENES OF QUITOSANE AND PREPARATION METHOD
NO20031841D0 (en) Triazole derivatives and pharmaceutical preparations containing them
NO20024823L (en) Medicinal preparations containing camptothecin derivative and pH regulating agent

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application